NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - NYSE:NUS - US67018T1051 - Common Stock
10.7 USD
-0.02 (-0.19%)
10.7 USD
0 (0%)
Overall NUS gets a fundamental rating of 5 out of 10. We evaluated NUS against 34 industry peers in the Personal Care Products industry. NUS has an excellent financial health rating, but there are some minor concerns on its profitability. NUS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year NUS was profitable.
NUS had a positive operating cash flow in the past year.
Of the past 5 years NUS 4 years were profitable.
NUS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of NUS (6.98%) is better than 67.65% of its industry peers.
The Return On Equity of NUS (12.80%) is better than 79.41% of its industry peers.
The Return On Invested Capital of NUS (3.88%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 12.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROIC | 3.88% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
NUS's Profit Margin of 6.20% is fine compared to the rest of the industry. NUS outperforms 70.59% of its industry peers.
Looking at the Operating Margin, with a value of 3.51%, NUS is in line with its industry, outperforming 47.06% of the companies in the same industry.
NUS's Operating Margin has declined in the last couple of years.
The Gross Margin of NUS (67.23%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
The number of shares outstanding for NUS has been increased compared to 1 year ago.
Compared to 5 years ago, NUS has less shares outstanding
NUS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.76 indicates that NUS is not in any danger for bankruptcy at the moment.
NUS's Altman-Z score of 3.76 is fine compared to the rest of the industry. NUS outperforms 70.59% of its industry peers.
The Debt to FCF ratio of NUS is 0.61, which is an excellent value as it means it would take NUS, only 0.61 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.61, NUS belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
A Debt/Equity ratio of 0.27 indicates that NUS is not too dependend on debt financing.
The Debt to Equity ratio of NUS (0.27) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 3.76 |
ROIC/WACC0.52
WACC7.52%
2.3 Liquidity
A Current Ratio of 2.01 indicates that NUS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.01, NUS is in line with its industry, outperforming 50.00% of the companies in the same industry.
NUS has a Quick Ratio of 1.38. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
NUS's Quick ratio of 1.38 is in line compared to the rest of the industry. NUS outperforms 55.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The earnings per share for NUS have decreased by -1.63% in the last year.
NUS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.85% yearly.
NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.80%.
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.47% yearly.
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
3.2 Future
NUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.15% yearly.
The Revenue is expected to decrease by -5.71% on average over the next years.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.84, the valuation of NUS can be described as reasonable.
Based on the Price/Earnings ratio, NUS is valued cheaply inside the industry as 91.18% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of NUS to the average of the S&P500 Index (26.51), we can say NUS is valued rather cheaply.
A Price/Forward Earnings ratio of 6.79 indicates a rather cheap valuation of NUS.
Based on the Price/Forward Earnings ratio, NUS is valued cheaper than 94.12% of the companies in the same industry.
NUS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.53, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.84 | ||
| Fwd PE | 6.79 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.18% of the companies listed in the same industry.
NUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUS is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.29 | ||
| EV/EBITDA | 4.34 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NUS's earnings are expected to grow with 36.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.96, NUS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, NUS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NUS pays out 11.83% of its income as dividend. This is a sustainable payout ratio.
DP11.83%
EPS Next 2Y36.15%
EPS Next 3YN/A
10.7
-0.02 (-0.19%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change-0.25%
Ins Owners2.08%
Ins Owner Change3.24%
Market Cap529.65M
Revenue(TTM)1.63B
Net Income(TTM)100.83M
Analysts45
Price Target7.65 (-28.5%)
Short Float %4.5%
Short Ratio3.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP11.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.8%
Min EPS beat(2)73.77%
Max EPS beat(2)73.83%
EPS beat(4)3
Avg EPS beat(4)52.6%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)40.86%
EPS beat(12)9
Avg EPS beat(12)30.24%
EPS beat(16)13
Avg EPS beat(16)24.81%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.5%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)0%
EPS NY rev (3m)27.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.84 | ||
| Fwd PE | 6.79 | ||
| P/S | 0.33 | ||
| P/FCF | 1.29 | ||
| P/OCF | 1.19 | ||
| P/B | 0.67 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | 4.34 |
EPS(TTM)1.21
EY11.31%
EPS(NY)1.58
Fwd EY14.73%
FCF(TTM)8.3
FCFY77.59%
OCF(TTM)9
OCFY84.15%
SpS32.86
BVpS15.91
TBVpS13.3
PEG (NY)0.18
PEG (5Y)N/A
Graham Number20.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROCE | 4.92% | ||
| ROIC | 3.88% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 5.89% | ||
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% | ||
| FCFM | 25.27% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 56.99% | ||
| Cap/Sales | 2.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 377.59% | ||
| Profit Quality | 407.56% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.76 |
F-Score6
WACC7.52%
ROIC/WACC0.52
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21528.6%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y561.31%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 8.84 and the Price/Book (PB) ratio is 0.67.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 11.83%.